Catalyst

Slingshot members are tracking this event:

Ad Com Review of Paratek Pharma's (PRTK) Omadacycline NDA briefing documents released

Source Link:
https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM615848.pdf

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
PRTK
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details 1 July 2018: Briefing materials presented by the company to the FDA
https://www.fda.gov/...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Aug 06, 2018
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Omadacycline
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.